Cargando…

Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice with a large socioeconomic impact due to its associated morbidity, mortality, reduction in quality of life and health care costs. Currently, antiarrhythmic drug therapy is the first line of treatment for most symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gorp, Pim R. R., Trines, Serge A., Pijnappels, Daniël A., de Vries, Antoine A. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138102/
https://www.ncbi.nlm.nih.gov/pubmed/32296716
http://dx.doi.org/10.3389/fcvm.2020.00043
_version_ 1783518533583372288
author van Gorp, Pim R. R.
Trines, Serge A.
Pijnappels, Daniël A.
de Vries, Antoine A. F.
author_facet van Gorp, Pim R. R.
Trines, Serge A.
Pijnappels, Daniël A.
de Vries, Antoine A. F.
author_sort van Gorp, Pim R. R.
collection PubMed
description Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice with a large socioeconomic impact due to its associated morbidity, mortality, reduction in quality of life and health care costs. Currently, antiarrhythmic drug therapy is the first line of treatment for most symptomatic AF patients, despite its limited efficacy, the risk of inducing potentially life-threating ventricular tachyarrhythmias as well as other side effects. Alternative, in-hospital treatment modalities consisting of electrical cardioversion and invasive catheter ablation improve patients' symptoms, but often have to be repeated and are still associated with serious complications and only suitable for specific subgroups of AF patients. The development and progression of AF generally results from the interplay of multiple disease pathways and is accompanied by structural and functional (e.g., electrical) tissue remodeling. Rational development of novel treatment modalities for AF, with its many different etiologies, requires a comprehensive insight into the complex pathophysiological mechanisms. Monolayers of atrial cells represent a simplified surrogate of atrial tissue well-suited to investigate atrial arrhythmia mechanisms, since they can easily be used in a standardized, systematic and controllable manner to study the role of specific pathways and processes in the genesis, perpetuation and termination of atrial arrhythmias. In this review, we provide an overview of the currently available two- and three-dimensional multicellular in vitro systems for investigating the initiation, maintenance and termination of atrial arrhythmias and AF. This encompasses cultures of primary (animal-derived) atrial cardiomyocytes (CMs), pluripotent stem cell-derived atrial-like CMs and (conditionally) immortalized atrial CMs. The strengths and weaknesses of each of these model systems for studying atrial arrhythmias will be discussed as well as their implications for future studies.
format Online
Article
Text
id pubmed-7138102
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71381022020-04-15 Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation van Gorp, Pim R. R. Trines, Serge A. Pijnappels, Daniël A. de Vries, Antoine A. F. Front Cardiovasc Med Cardiovascular Medicine Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice with a large socioeconomic impact due to its associated morbidity, mortality, reduction in quality of life and health care costs. Currently, antiarrhythmic drug therapy is the first line of treatment for most symptomatic AF patients, despite its limited efficacy, the risk of inducing potentially life-threating ventricular tachyarrhythmias as well as other side effects. Alternative, in-hospital treatment modalities consisting of electrical cardioversion and invasive catheter ablation improve patients' symptoms, but often have to be repeated and are still associated with serious complications and only suitable for specific subgroups of AF patients. The development and progression of AF generally results from the interplay of multiple disease pathways and is accompanied by structural and functional (e.g., electrical) tissue remodeling. Rational development of novel treatment modalities for AF, with its many different etiologies, requires a comprehensive insight into the complex pathophysiological mechanisms. Monolayers of atrial cells represent a simplified surrogate of atrial tissue well-suited to investigate atrial arrhythmia mechanisms, since they can easily be used in a standardized, systematic and controllable manner to study the role of specific pathways and processes in the genesis, perpetuation and termination of atrial arrhythmias. In this review, we provide an overview of the currently available two- and three-dimensional multicellular in vitro systems for investigating the initiation, maintenance and termination of atrial arrhythmias and AF. This encompasses cultures of primary (animal-derived) atrial cardiomyocytes (CMs), pluripotent stem cell-derived atrial-like CMs and (conditionally) immortalized atrial CMs. The strengths and weaknesses of each of these model systems for studying atrial arrhythmias will be discussed as well as their implications for future studies. Frontiers Media S.A. 2020-03-31 /pmc/articles/PMC7138102/ /pubmed/32296716 http://dx.doi.org/10.3389/fcvm.2020.00043 Text en Copyright © 2020 van Gorp, Trines, Pijnappels and de Vries. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
van Gorp, Pim R. R.
Trines, Serge A.
Pijnappels, Daniël A.
de Vries, Antoine A. F.
Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
title Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
title_full Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
title_fullStr Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
title_full_unstemmed Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
title_short Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
title_sort multicellular in vitro models of cardiac arrhythmias: focus on atrial fibrillation
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138102/
https://www.ncbi.nlm.nih.gov/pubmed/32296716
http://dx.doi.org/10.3389/fcvm.2020.00043
work_keys_str_mv AT vangorppimrr multicellularinvitromodelsofcardiacarrhythmiasfocusonatrialfibrillation
AT trinessergea multicellularinvitromodelsofcardiacarrhythmiasfocusonatrialfibrillation
AT pijnappelsdaniela multicellularinvitromodelsofcardiacarrhythmiasfocusonatrialfibrillation
AT devriesantoineaf multicellularinvitromodelsofcardiacarrhythmiasfocusonatrialfibrillation